Poland· PL-100104162

Silimax

A silymarin product containing silymarinum, registered in Poland by Farmaceutyczna Spółdzielnia Pracy FILOFARM. The same ATC class is registered in 5 of our 19 countries.

ATC A05BA03

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedSilimaxATCA05BA03REGISTER NO.PL-100104162PACKS LISTED4CHECKEDSeptember 27, 2026

Where it is registered

Silymarin is registered in 5 of 19 countries.

Countries holding a registration under ATC A05BA03 (silymarin), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 5 of them publish a price we can compare per daily dose

Silymarin · ATC A05BA03

5 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Silymarinum
Manufacturer
Farmaceutyczna Spółdzielnia Pracy FILOFARM
Country
Poland (PL)
ATC code
A05BA03
ATC class
Silymarin
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 4

  • gtin
    05909990899029
  • gtin
    05909990899036
  • gtin
    05903270612308
  • gtin
    05909990899012

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Silymarin in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All silymarin products

Authorised across Europe · EMA

The same active substance is authorised in 9 EEA countries. Names it is sold under:

  • Bulgaria · Карсил, Карсил Макс
  • Czechia · Lagosa
  • Germany · Silymarin Ct, Silymarin Forte Stada
  • Spain · Legalon
  • France · Legalon
  • Croatia · Silymarin Belupo, Silymarin Forte Belupo
  • Italy · Silimarin, Silmar
  • Portugal · Legalon
  • Romania · Silibină Arena

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/6cb7f47e-9938-4563-8707-3315cd138d2f
GET /v1/drugs/6cb7f47e-9938-4563-8707-3315cd138d2f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki twarde",
  "source": "urpl",
  "strength": "70 mg",
  "packaging": "05909990899012 ¦ OTC ¦ Skasowane ¦ 17988\n30 kaps. w blistrze\n05909990899029 ¦ OTC ¦ Skasowane ¦ 17989\n30 kaps. w pojemniku\n05909990899036 ¦ OTC ¦ 25749\n30 kaps.\n05903270612308 ¦ OTC ¦ 137044\n36 kaps.",
  "substance": "Silimarinum 70 mg",
  "common_name": "Silymarinum",
  "pl_product_id": "100104162",
  "pozwolenie_nr": "08990",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about silymarin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.